Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

23 May 2023 07:00

RNS Number : 2624A
Caledonia Investments PLC
23 May 2023
 

 

 

APPOINTMENT OF CHIEF FINANCIAL OFFICER

 

The board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce that it has appointed Rob Memmott as Caledonia's Chief Financial Officer with effect from 1 September 2023.

 

Rob, a chartered accountant, has over 20 years' experience in senior financial leadership roles. He has significant listed company experience, having previously served as CFO of Arrow Global Group plc for seven years, which included its successful IPO, and John Laing Group plc before its take private transaction with KKR. Prior to this he was Finance Director of Leeds Bradford International Airport and Alfred McAlpine Infrastructure Services and CFO at Servisair-Globeground. Rob is also Treasurer and Pro Chancellor of the University of Sheffield.

 

Tim Livett, Caledonia's current Chief Financial Officer who advised Caledonia's board of his intention to retire in November 2022 once a suitable successor had been identified, will step down as a director on 1 September 2023 and leave the Company on 31 October 2023, to enable a smooth handover with Rob.

 

Commenting on the appointment, Mat Masters, Caledonia's Chief Executive Officer, said:

 

"We are delighted that Rob Memmott will be joining Caledonia. We expect his listed company and finance experience, across a range of industries and sectors will be highly complementary to our management team."

 

"I would also like again to extend the board's thanks to Tim Livett for his contribution to Caledonia and we wish him every success as he pursues a portfolio of non-executive roles."

 

Rob Memmott said:

 

"I am excited to be joining Caledonia, a company with a fantastic heritage built on a proven approach of investing in high-quality assets to create long-term value. I look forward to working with Mat and the team as we look to the opportunities ahead."

 

23 May 2023

 

For further information please contact:

 

Caledonia Investments plc

+44 20 7802 8080

Mat Masters

Chief Executive Officer

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

 

 

Notes:

 

1.

Mr Memmott served as Chief Financial Officer of John Laing Group plc before the company delisted on 23 September 2021. There are no further disclosures to be made pursuant to LR 9.6.13.

 

2.

Mr Memmott's remuneration package will be in accordance with Caledonia's approved remuneration policy. No special sign-on commitments or compensation payments for loss of benefits from a previous employer will be made in relation to his appointment.

 

3.

Information required by section 430 (2B) of the Companies Act 2006 relating to Mr Livett's cessation as a director of the Company will be available on Caledonia's website in due course.

 

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. We achieve this by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUQCAUPWGRP
Date   Source Headline
15th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.